Medications starting with
Ukraine-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis), as well as anemia in patients undergoing chemotherapy for tumors or lymphomas. It is also used to facilitate autologous blood collection before surgery and in certain types of blood disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 1000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and for patients with certain types of bone marrow disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 2000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or without dialysis), as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain types of blood disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 3000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or without dialysis), as well as anemia caused by chemotherapy in oncological diseases. It is also used to facilitate autologous blood collection in patients before surgery and in certain types of bone marrow disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 4000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis), as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain hematological disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 10 000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors or lymphomas. It is also used to facilitate autologous blood collection before surgery and in certain types of bone marrow disorders (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 20000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to treat anemia associated with chronic kidney disease (in adults and children on dialysis or non-dialysis) as well as anemia in patients undergoing chemotherapy for tumors, lymphomas, or myeloma. It is also used to facilitate autologous blood collection before surgery and in certain hematological diseases (MDS).
Dosage form: lyophilisate for solution for injection
Active substance Dosage epoetin alfa 40 000 IU ATC code: B03XA01
Manufacturer: Biosidus S.A. (manufacturing of unpackaged product, primary and secondary packaging; quality control, batch release)
-
The drug is used to stop bleeding or prevent it if it is associated with an increased process of clot breakdown (fibrinolysis). This applies to both general conditions (e.g., during surgery) and local bleeding (uterine, gastrointestinal, after tooth extraction, or certain surgical interventions).
Dosage form: solution for injection
Active substance Dosage tranexamic acid 50 mg/ml ATC code: B02AA02
Manufacturer: Farmasel LLC (full cycle; control, batch release)
-
The drug is intended for routine prophylaxis to prevent or reduce the frequency of bleeding in adults and children (from birth) with hemophilia A.
Dosage form: solution for injection
Active substance Dosage emactuzumab 150 mg/ml ATC code: B02BX06
-
The drug is intended for the prevention and reduction of the frequency of bleeding in adults and children (from birth) with hemophilia A (congenital deficiency of coagulation factor VIII).
Dosage form: solution for injection
Active substance Dosage active substance 30 mg/ml or 30 mg/ml ATC code: B02BX06
-
The drug is used to stop bleeding or prevent it in cases of increased clot dissolution (fibrinolysis). It is prescribed to adults and children from 1 year of age for gastrointestinal bleeding, gynecological issues (e.g., heavy menstruation), after dental or surgical interventions, as well as for controlling bleeding when using other specific medications.
Dosage form: solution for injection
Active substance Dosage tranexamic acid 100 mg/ml ATC code: B02AA02
Manufacturer: Immacul Lifesciences Private Limited
-
The drug is used to treat iron-deficiency and folate-deficiency anemia. It is also prescribed for conditions where the body requires more iron, such as during pregnancy, breastfeeding, periods of rapid growth, after surgery, or in cases of bleeding.
Dosage form: solution, oral
Active substance Dosage ammonium ferric citrate 40 mg/ml folic acid 0.3 mg/ml cyanocobalamin 0.01 mg/ml ATC code: B03AE01
Manufacturer: Joint Ukrainian-Spanish Enterprise "Sperko Ukraine"
-
The drug is used for the symptomatic treatment of hemorrhoids and anal fissures.
Dosage form: suppositories, rectal
Active substance Dosage benzocaine 100 mg bismuth subgallate 40 mg zinc oxide 20 mg menthol 4 mg ATC code: C05AD03
Manufacturer: Farmex Group LLC
-
The drug is used for the treatment of hemorrhoids, chronic proctitis, and anal fissures.
Dosage form: suppositories
Active substance Dosage benzocaine 100 mg chamomile flower head extract dense 50 mg belladonna root extract dry 20 mg complex dry extract (juniper herb horse chestnut bark erect spurge herb) 80 mg ATC code: C05AD
Manufacturer: Wroclaw Herbal Pharmaceuticals Enterprise "HERBAPOL" JSC
-
The drug is used to treat hemorrhoids accompanied by sensations of burning, itching, and discomfort.
Dosage form: ointment, for external and rectal use
Active substance Dosage phenylephrine 2.5 mg shark liver oil 30.0 mg ATC code: C05AX03
Manufacturer: Pharmasciences Inc.
-
The drug is used for short-term therapy of bleeding or the risk of its occurrence. It is applied for nosebleeds, excessive menstrual bleeding (menorrhagia), after certain surgeries (on the bladder or prostate), during cervical conization, post-traumatic hyphema, hereditary angioedema, as well as during tooth extraction in patients with hemophilia.
Dosage form: tablets, film-coated
Active substance Dosage tranexamic acid 500 mg ATC code: B02AA02
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of people with diabetes mellitus who require insulin therapy.
Dosage form: solution for injection
Active substance Dosage human insulin 100 IU/ml ATC code: A10AB01
Manufacturer: BIOTON S.A. (manufacturer responsible for manufacturing, primary and secondary packaging, quality control and batch release)
-
The drug is used to treat intrahepatic cholestasis in adults (including in cases of chronic hepatitis and liver cirrhosis), as well as in pregnant women. Additionally, it is used for depressive syndromes.
Dosage form: lyophilisate for solution for injection
Active substance Dosage adenosylmethionine 400 mg ATC code: A16AA02
Manufacturer: Farmak JSC
-
The drug is prescribed for the treatment of intrahepatic cholestasis in adults (including chronic hepatitis and liver cirrhosis), as well as in pregnant women. It is also used for depressive syndromes.
Dosage form: tablets, enteric-coated
Active substance Dosage adenosylmethionine 400 mg ATC code: A16AA02
Manufacturer: Farmak JSC
-
The drug is used for the symptomatic treatment of hepatic encephalopathy (in both latent and overt forms).
Dosage form: concentrate for infusion solution
Active substance Dosage ornithine 5 g/10 ml aspartic acid 5 g/10 ml ATC code: A05BA
Manufacturer: Merck Pharma GmbH & Co. KGaA (quality control testing and batch release)
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in liver cirrhosis) accompanied by symptoms of hepatic encephalopathy.
Dosage form: granules
Active substance Dosage ornithine 3 g aspartic acid 0 ATC code: A05BA
-
The drug is used to treat infections caused by susceptible microorganisms, including respiratory tract infections, urinary tract infections, skin, soft tissue, bone, and joint infections, as well as peritonitis, cholecystitis, septicemia, meningitis, and genital tract infections.
Dosage form: powder for injection solution
Active substance Dosage cefoperazone 1.0 g sulbactam 1.0 g ATC code: J01DD62
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat infections caused by microorganisms sensitive to it. Specifically, it is used for infections of the respiratory tract, urinary tract, skin, bones, joints, and genital tract, as well as for peritonitis, septicemia, meningitis, and for the prevention of post-operative complications.
Dosage form: powder for injection solution
Active substance Dosage cefoperazone 1 g ATC code: J01DD12
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used as part of complex therapy for acute and chronic hepatitis, liver cirrhosis, fatty dystrophy (steatosis), alcoholic liver disease, as well as for intoxication due to long-term intake of antineoplastic or anti-tuberculosis drugs.
Dosage form: powder for injection solution
Active substance Dosage orotic acid carnitine 300.0 mg levocarnitine hydrochloride 184.0 mg antitoxic fraction of liver extract 25.0 mg adenosine 5.0 mg pyridoxine hydrochloride 25.0 mg cyanocobalamin 0.25 mg ATC code: A16AA
Manufacturer: Farmeks Group LLC (manufacturing, packaging, quality control)
-
The drug is used as part of complex therapy for acute and chronic hepatitis, liver cirrhosis, fatty dystrophy (steatosis), alcoholic liver disease, as well as for intoxication due to long-term intake of antineoplastic or anti-tuberculosis drugs.
Dosage form: capsules
Active substance Dosage orotic acid carnitine 150 mg antitoxic fraction of liver extract 12.5 mg pyridoxine hydrochloride 25.0 mg cyanocobalamin 0.125 mg adenine hydrochloride 2.5 mg riboflavin 0.5 mg ATC code: A16AA
Manufacturer: VALARTIN PHARMA LLC
-
The drug is used to treat intrahepatic cholestasis in adults (including chronic hepatitis and liver cirrhosis), as well as in pregnant women. Additionally, it is prescribed for depressive syndromes.
Dosage form: lyophilisate for solution for injection
Active substance Dosage adenosylmethionine 400 mg ATC code: A16AA02
Manufacturer: PJSC "Kyivmedpreparat" (manufacturer of lyophilizate, responsible for batch release of finished medicinal product)
-
The drug is prescribed for the treatment of intrahepatic cholestasis in adults (including chronic hepatitis and liver cirrhosis), as well as in pregnant women.
Dosage form: lyophilisate for solution for injection
Active substance Dosage adenosylmethionine 500 mg ATC code: A16AA02
Manufacturer: PJSC "Galichfarm" (manufacturing of solvent)
-
The drug is prescribed for the treatment of intrahepatic cholestasis in adults (including chronic hepatitis and liver cirrhosis), as well as in pregnant women.
Dosage form: tablets, enteric-coated
Active substance Dosage adenosylmethionine 500 mg ATC code: A16AA02
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat superficial vein diseases (varicose veins, thrombophlebitis, phlebothrombosis), as well as for injuries, bruises, swelling, hematomas, and muscle or ligament strains.
Dosage form: gel
Active substance Dosage sodium heparin 1000 IU/g ATC code: C05BA03
Manufacturer: LLC "Pharmaceutical Company "Vertex" (manufacturing of products in bulk LLC "Pharmaceutical Company "Zdorovya", Ukraine)
-
The drug is used for the prevention and treatment of superficial vein thrombophlebitis, inflammation of veins after injections, trophic ulcers, edema, injuries and bruises without skin damage, as well as for external hemorrhoids and mastitis.
Dosage form: ointment
Active substance Dosage sodium heparin 100 IU/g benzocaine 40 mg/g ATC code: C05BA53
Manufacturer: DKP "Pharmaceutical Factory" LLC
-
The drug is used for the prevention and treatment of thromboembolic diseases (e.g., venous or arterial thrombosis, acute coronary syndrome), as well as to prevent blood clotting during surgery, dialysis, or blood transfusion.
Dosage form: solution for injection
Active substance Dosage sodium heparin 5000 IU/ml ATC code: B01AB01
Manufacturer: Biolik Pharma LLC
-
The drug is used to treat diseases of the superficial veins (varicose veins, thrombophlebitis, phlebothrombosis), as well as for injuries, bruises, edema, hematomas, and muscle or ligament sprains.
Dosage form: gel
Active substance Dosage sodium heparin 600 IU/g ATC code: C05BA03
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used for the prevention and treatment of thromboembolic diseases (e.g., thrombosis of veins, arteries, cerebral or ocular vessels), to prevent thrombosis after surgery, and to prevent blood clotting during laboratory tests, dialysis, or heart surgery.
Dosage form: solution for injection
Active substance Dosage sodium heparin 5000 IU/ml ATC code: B01AB01
Manufacturer: Farmex Group LLC
-
The drug is used for the prevention and treatment of thromboembolic diseases (e.g., thrombosis of veins, arteries, cerebral or ocular vessels), as well as to prevent blood clotting during surgery, dialysis, or blood transfusion.
Dosage form: solution for injection
Active substance Dosage sodium heparin 5000 IU/ml ATC code: B01AB01
Manufacturer: PJSC "Production of Insulins "Indar"
-
The drug is used for the prevention and treatment of thromboembolic diseases (e.g., venous and arterial thrombosis, myocardial infarction), as well as to prevent blood clotting during surgery, dialysis, or blood transfusion.
Dosage form: solution for injection
Active substance Dosage sodium heparin 5000 IU/ml ATC code: B01AB01
Manufacturer: LLC Firm Novofarm-Biosyntez
-
The drug is used to improve liver function in cases of chronic liver disease.
Dosage form: solution for injection
Active substance Dosage glycyrrhizin 40 mg glycine 400 mg l-cysteine 20 mg ATC code: A05BA
Manufacturer: Beijing Kevin Technology Share-Holding Co. LLC (quality control for pyrogens, batch release)
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in cirrhosis), especially if there are symptoms of hepatic encephalopathy, including impaired consciousness (precoma, coma).
Dosage form: concentrate for infusion solution
Active substance Dosage l-ornithine-l-aspartate 500 mg/ml ATC code: A05BA
-
The drug is used for the treatment of superficial vein diseases (varicose veins, thrombophlebitis, phlebothrombosis), as well as for injuries, bruises, swelling, and subcutaneous hematomas.
Dosage form: gel
Active substance Dosage sodium heparin 30000 IU/100 g ATC code: C05BA03
Manufacturer: Hemofarm AD, Vrsac, division Shabac (manufacturing of unpackaged products, primary and secondary packaging, batch control)
-
The drug is used for the treatment of superficial vein diseases (varicose veins, thrombophlebitis, phlebothrombosis), as well as for injuries, bruises, edema, and subcutaneous hematomas.
Dosage form: gel
Active substance Dosage sodium heparin 50000 IU/100 g ATC code: C05BA03
Manufacturer: Hemofarm AD, Vrsac, division Shabac (manufacturing of unpackaged products, primary and secondary packaging, batch control)
-
The drug is used for the treatment of superficial vein diseases (e.g., varicose veins, thrombophlebitis), as well as for injuries, bruises, swelling, and subcutaneous hematomas.
Dosage form: cream
Active substance Dosage sodium heparin 30000 IU/100 g ATC code: C05BA03
Manufacturer: Hemofarm AD, Vrsac, division Shabac (manufacturing of unpackaged products, primary and secondary packaging, batch control)
-
The drug is used for the treatment of superficial vein diseases (e.g., varicose veins and their complications, thrombophlebitis), as well as for injuries, bruises, swelling, and subcutaneous hematomas.
Dosage form: cream
Active substance Dosage sodium heparin 50000 IU/100 g ATC code: C05BA03
Manufacturer: Hemofarm AD, Vrsac, division Shabac (manufacturing of unpackaged products, primary and secondary packaging, batch control)
-
The drug is used for the prevention of neuropathy caused by cisplatin chemotherapy or similar substances. It is also prescribed for hepatotoxicity reactions (liver damage) caused by alcohol, medications, or impaired detoxification processes.
Dosage form: powder for injection solution
Active substance Dosage glutathione 600 mg ATC code: V03AB32
Manufacturer: Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.
-
The drug is used for the prevention of neuropathy caused by cisplatin chemotherapy or similar substances.
Dosage form: powder for injection solution
Active substance Dosage glutathione 600 mg ATC code: V03AB32
-
The product is used for the treatment of various skin and mucosal lesions, including abrasions, burns, postoperative wounds, skin grafts, as well as bullous and vesicular dermatitis.
Dosage form: spray, topical
Active substance Dosage dexpanthenol 50 mg allantoin 1 mg ATC code: D03AX03
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The drug is used for the treatment and prevention of iron deficiency anemia.
Dosage form: capsules
Active substance Dosage ferrous fumarate 350 mg ATC code: B03AA02
Manufacturer: ALKALOID AD Skopje
-
The cream is used to treat minor abrasions, scratches, cuts, excoriations, fissures, and minor burns, as well as to prevent their infection. It is also used for skin infections, nipple fissures in breastfeeding women, for the treatment of post-operative wounds, pressure ulcers, and radiation ulcers.
Dosage form: cream
Active substance Dosage dexpanthenol 50 mg benzalkonium chloride 0.5 mg chlorhexidine digluconate 38.8 mg ATC code: D03AX
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The cream is used for the prevention of dry and irritated skin, as well as to accelerate the healing of scratches, minor burns, cracks, diaper dermatitis, pressure sores, and erosions. It is also suitable for breast care in breastfeeding women and for the treatment of cervical mucosal defects.
Dosage form: cream for external use
Active substance Dosage dexpanthenol 50 mg/g ATC code: D03AX03
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The product is used to treat various skin and mucosal lesions, specifically for abrasions, burns, bullous dermatitis, as well as aseptic postoperative wounds and skin grafts.
Dosage form: spray, topical
Active substance Dosage dexpanthenol 50 mg/g ATC code: D03AX03
Manufacturer: LLC "Pharmaceutical Company "Zdorovya"
-
The drug is used for the local treatment of diseases of the oral mucosa and oropharynx. It has antibacterial and analgesic effects.
Dosage form: spray, oral cavity
Active substance Dosage hexetidine 1 mg/ml choline salicylate 5 mg/ml chlorobutanol 2.5 mg/ml ATC code: R02AA20
Manufacturer: Farmak JSC
-
The drug is used for the local treatment of oral cavity infections, as well as for post-operative dental care.
Dosage form: solution, oral
Active substance Dosage hexetidine 0.1 g/100 mL choline salicylate 0.5 g/100 ml chlorobutanol 0.25 g/100 ml ATC code: R02AA20
Manufacturer: Farmak JSC